Recent Patents on Inflammation & Allergy Drug Discovery

289 papers and 5.5k indexed citations i.

About

The 289 papers published in Recent Patents on Inflammation & Allergy Drug Discovery in the last decades have received a total of 5.5k indexed citations. Papers published in Recent Patents on Inflammation & Allergy Drug Discovery usually cover Physiology (41 papers), Dermatology (38 papers) and Molecular Biology (37 papers) specifically the topics of Asthma and respiratory diseases (36 papers), Allergic Rhinitis and Sensitization (26 papers) and Food Allergy and Anaphylaxis Research (22 papers). The most active scholars publishing in Recent Patents on Inflammation & Allergy Drug Discovery are Alexander K. C. Leung, Yadollah Shakiba, Mahdi Mahmoudi, Nemat Khansari, Kam‐Lun Ellis Hon, Alex H.C. Wong, Daisuke Tsuruta, Jiexiong Feng, Jia Wei and Amy A.M. Leung.

In The Last Decade

Fields of papers published in Recent Patents on Inflammation & Allergy Drug Discovery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Recent Patents on Inflammation & Allergy Drug Discovery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Recent Patents on Inflammation & Allergy Drug Discovery.

Countries where authors publish in Recent Patents on Inflammation & Allergy Drug Discovery

Since Specialization
Citations

This map shows the geographic impact of research published in Recent Patents on Inflammation & Allergy Drug Discovery. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Recent Patents on Inflammation & Allergy Drug Discovery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Recent Patents on Inflammation & Allergy Drug Discovery more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025